Oral rivaroxaban for postoperative prophylaxis of venous thromboembolism after sleeve gastrectomy in patients with morbid obesity, is it safe: A prospective randomized clinical t

Is rivaroxaban a safe and effective oral alternative to low-molecular-weight heparin in prophylaxis of portomesenteric and lower-limb deep-vein thrombosis after sleeve gastrectomy

Value of pharmacologic thromboprophylaxis for prevention of thromboembolic complications in bariatric surgery

Postoperative enoxaparin vs fondaparinux in prophylaxis against venous thromboembolism in patients undergoing laparoscopic sleeve gastrectomy

Short Term Evaluation of Warfarin Versus Rivaroxaban Regimens in the Treatment of Deep Venous Thrombosis

EFFICACY AND SAFETY OUTCOMES OF RIVAROXABAN IN ACUTE DEEP VENOUS THROMBOSIS PATIENTS

Rivaroxaban versus Warfarin in Treatment of Acute Lower Limb Deep Venous Thrombosis and its Affection on Quality of Life.

Comparative study of safety and effectiveness of rivaroxaban and warfarin in patients with acute deep venous thrombosis

Comparative Study between Rivaroxaban and Warfarin inTreatment of Patients with Recurrent Deep Venous Thrombosis

Safety and Mortality: Monitoring the Patients on Rivaroxaban